| Financial Year |
March 31 2023 |
| Monetary Funds |
2,861,191,662.94 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
8,568,802.42 |
| Accounts Receivable |
109,870,082.37 |
| Advances to Suppliers |
6,864,051.64 |
| Other Receivables |
10,291,389.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
308,456,491.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
22,499,764.21 |
| Total Current Assets |
3,341,344,543.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
19,306,960.08 |
| Fixed Assetes |
228,819,821.94 |
| Under-construction Projects |
66,999,137.25 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
15,356,581.69 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,342,996.95 |
| Deferred Income Tax Assets |
11,754,535.08 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
372,406,270.43 |
| Total Assets |
3,713,750,814.03 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
157,938,454.16 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
110,905,658.62 |
| Taxes Payable |
7,366,325.77 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
29,462,143.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,740,247.25 |
| Other Current Liabilities |
16,046,968.20 |
| Sub-Total of Current Liabilities |
454,898,014.73 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
19,696,272.89 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
32,200,538.31 |
| Total Liabilities |
487,098,553.04 |
| Paid-In Capital(Or Share Stock) |
643,829,039.00 |
| Capital Surplus |
1,459,117,270.11 |
| Surplus Reserve |
129,586,256.03 |
| LESS:Treasury Stock |
99,886,768.67 |
| Undistributed Profits |
1,094,006,464.52 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,226,652,260.99 |
| Owner's Equity（Stockholder's Equity） |
3,226,652,260.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,713,750,814.03 |
